Nasal versus bronchial and nasal response to oral aspirin challenge Monika Swierczynska, MD, Ewa Nizankowska-Mogilnicka, MD, PhD, Jacek Zarychta, MD, Anna Gielicz, PhD, Andrzej Szczeklik, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 112, Issue 5, Pages 995-1001 (November 2003) DOI: 10.1016/S0091-6749(03)02015-3

FIG 1 Mean baseline uLTE4 (expressed as log uLTE4 change in time) excretion in BNR and NR groups. ∗Statistically significant compared with baseline (also see Table I). Journal of Allergy and Clinical Immunology 2003 112, 995-1001DOI: (10.1016/S0091-6749(03)02015-3)

FIG 2 Mean baseline serum levels of 9α,11beta;-PGF2 (expressed as log s9alpha;,11beta;-PGF2 change in time) in BNR and the NR groups. ∗Statistically significant compared with baseline (also see Table II). Journal of Allergy and Clinical Immunology 2003 112, 995-1001DOI: (10.1016/S0091-6749(03)02015-3)